Patents by Inventor Ofer Levi
Ofer Levi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11850026Abstract: Devices and methods are provided for performing remote physiological monitoring of vital signs from one or more subjects. Camera pairs including an intensity camera and a depth camera are used to obtain intensity image data and depth image data that are then processed using one or more ROIs for extracting heart rate and respiratory waveforms from which the heart rate and respiratory rate may be estimated. In other embodiments, multiple ROIs may be used to obtain several heart rate and respiratory rate values which are then fused together. In some embodiments motion compensation may be used prior to generating the heart rate and respiratory waveforms. In other embodiments, multiple camera pairs may be used to obtain intensity and depth data from multiple fields of view which may be used to obtain several heart rate and respiratory rate values which are then fused together.Type: GrantFiled: June 24, 2021Date of Patent: December 26, 2023Inventors: Ofer Levi, Eric Y. Zhu, Dene Alexander Adrian Ringuette, Ryan Chu
-
Publication number: 20210409135Abstract: System for determining the efficiency of publicity and/or broadcasted programs, comprising an audio signature generating unit with an adaptor that consists of a sampling unit for sampling the audio signal transmitted by the radio/TV at a first rate; a transformer, for obtaining galvanic separation between the power amplifier of the radio/TV, which feeds the loudspeakers and the input to the sampling circuitry. The audio signature generating unit is adapted to sample the audio signal transmitted by the receiver radio/TV that receives FM-radio/TV stations and to generate a characteristic audio signature. The system also comprises a plurality of stationary reference station units, each continuously listens to a station and is adapted to sample the audio signal transmitted by a particular broadcasting station to generate a stationary characteristic audio signature.Type: ApplicationFiled: January 8, 2018Publication date: December 30, 2021Applicant: O.Z. 89 Ltd.Inventors: Ofer LEVI, Zvi SHALOM
-
Publication number: 20210401298Abstract: Devices and methods are provided for performing remote physiological monitoring of vital signs from one or more subjects. Camera pairs including an intensity camera and a depth camera are used to obtain intensity image data and depth image data that are then processed using one or more ROIs for extracting heart rate and respiratory waveforms from which the heart rate and respiratory rate may be estimated. In other embodiments, multiple ROIs may be used to obtain several heart rate and respiratory rate values which are then fused together. In some embodiments motion compensation may be used prior to generating the heart rate and respiratory waveforms. In other embodiments, multiple camera pairs may be used to obtain intensity and depth data from multiple fields of view which may be used to obtain several heart rate and respiratory rate values which are then fused together.Type: ApplicationFiled: June 24, 2021Publication date: December 30, 2021Inventors: Ofer Levi, Eric Y. Zhu, Dene Alexander Adrian Ringuette, Ryan Chu
-
Patent number: 11189363Abstract: A method of characterizing chemical and/or morphological features of a material, comprising acquiring energy relaxation data from 1H low field nuclear magnetic resonance (1H LF-NMR) measurements of said material, converting the relaxation signals into a multidimensional distribution of longitudinal and transverse relaxation times by solving an inverse problem under both L1 and L2 regularizations and further imposing a non-negativity constraint, and identifying one or more characteristics of said material with the aid of said multidimensional T1-T2 distribution. The method is useful, inter alia, in monitoring chemical processes, screening of additives and quality control.Type: GrantFiled: September 6, 2019Date of Patent: November 30, 2021Inventors: Ze'ev Wiesman, Charles Linder, Ofer Levi
-
Publication number: 20200241095Abstract: A method of characterizing chemical and/or morphological features of a material, comprising acquiring energy relaxation data from 1H low field nuclear magnetic resonance (1H LF-NMR) measurements of said material, converting the relaxation signals into a multidimensional distribution of longitudinal and transverse relaxation times by solving an inverse problem under both L1 and L2 regularizations and further imposing a non-negativity constraint, and identifying one or more characteristics of said material with the aid of said multidimensional T1-T2 distribution. The method is useful, inter alia, in monitoring chemical processes, screening of additives and quality control.Type: ApplicationFiled: September 6, 2019Publication date: July 30, 2020Inventors: Ze'ev WIESMAN, Charles LINDER, Ofer LEVI
-
Publication number: 20200002416Abstract: This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.Type: ApplicationFiled: May 14, 2019Publication date: January 2, 2020Inventors: Gady S. COJOCARU, Galit ROTMAN, Zurit LEVINE, Liat DASSA, Ofer LEVI, Raffaella BRIANTE, Shweta SINGH, Susan R. WATSON, Tania PERGAM
-
Publication number: 20170233473Abstract: This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.Type: ApplicationFiled: February 28, 2017Publication date: August 17, 2017Applicant: Compugen Ltd.Inventors: Gady S. COJOCARU, Galit ROTMAN, Zurit LEVINE, Liat DASSA, Ofer LEVI, Raffaella BRIANTE, Shweta SINGH, Susan R. WATSON, Tania PERGAM
-
Patent number: 9617336Abstract: This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.Type: GrantFiled: January 31, 2013Date of Patent: April 11, 2017Assignee: COMPUGEN LTDInventors: Gady S. Cojocaru, Galit Rotman, Zurit Levine, Liat Dassa, Ofer Levi, Raffaella Briante, Shweta Singh, Susan R. Watson, Tania Pergam
-
Patent number: 9555087Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants awhich are suitable targets for immunotherapy, cancer therapy, and drug development.Type: GrantFiled: August 26, 2014Date of Patent: January 31, 2017Assignee: COMPUGEN LTDInventors: Amir Toporik, Amit Novik, Anat Cohen-Dayag, Avi Yeshah Rosenberg, Cynthia Koifman, Dalit Landesman-Milo, Eve Montia, Galit Rotman, Liat Dassa, Marina Bubis, Merav Beiman, Ofer Levi, Sergey Nemzer, Tania Pergam, Yaron Kinar, Shirley Sameach- Greenwald, Zurit Levine, Shira Walach
-
Patent number: 9253419Abstract: The present invention uses vertical-cavity surface-emitting lasers (VCSELs) as illumination source for simultaneous imaging of blood flow and tissue oxygenation dynamics in vivo, or a means to monitor neural activity in brain slices ex vivo. The speckle pattern on the brain tissue due to a VCSEL's coherence properties is the main challenge to producing low-noise high-brightness illumination, required for evaluating tissue oxygenation. Moreover, using oxide-confined VCSELs we show a fast switching from a single-mode operation scheme to a special multi-modal, multi-wavelength rapid sweep scheme. The multi-modal, multi-wavelength rapid sweep scheme reduces noise values to within a factor of 40% compared to non-coherent LED illumination, enabling high-brightness VCSELs to act as efficient miniature light sources for various brain imaging modalities and other imaging applications. These VCSELs are promising for long-term portable continuous monitoring of brain dynamics in freely moving animals.Type: GrantFiled: January 24, 2012Date of Patent: February 2, 2016Assignee: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTOInventors: Elizabeth Alice Munro, Ofer Levi
-
Publication number: 20150158947Abstract: This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.Type: ApplicationFiled: January 31, 2013Publication date: June 11, 2015Applicant: COMPUGEN LTD.Inventors: Gady S. Cojocaru, Galit Rotman, Zurit Levine, Liat Dassa, Ofer Levi, Raffaella Briante, Shweta Singh, Susan R. Watson, Tania Pergam
-
Publication number: 20140363446Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants awhich are suitable targets for immunotherapy, cancer therapy, and drug development.Type: ApplicationFiled: August 26, 2014Publication date: December 11, 2014Inventors: Amir TOPORIK, Amit NOVIK, Anat COHEN-DAYAG, Avi Yeshah ROSENBERG, Cynthia KOIFMAN, Dalit LANDESMAN-MILO, Eve MONTIA, Galit ROTMAN, Liat DASSA, Marina BUBIS, Merav BEIMAN, Ofer LEVI, Sergey NEMZER, Tania PERGAM, Yaron KINAR, Shirley SAMEACH- GREENWALD, Zurit LEVINE, Shira WALACH
-
Publication number: 20140294765Abstract: This invention relates to antibodies and antigen binding fragments and conjugates containing same, and/or alternative scaffolds, specific for LSR molecules, which are suitable drugs for immunotherapy and treatment of specific cancer.Type: ApplicationFiled: June 19, 2013Publication date: October 2, 2014Applicant: COMPUGEN LTD.Inventors: Gad S. Cojocaru, Liat Dassa, Galit Rotman, Ofer Levi, Andrew Pow, Shirley Sameach-Greenwald, Zurit Levine
-
Patent number: 8381263Abstract: A system, method, and computer program product are provided for allowing a non-chargeable event based on an authorization thereof. In use, an instruction to authorize events is received from an event threshold module based on a determination that an event threshold has been met. Additionally, in response to the instruction, a request is sent to an event processor to authorize an event, where the authorization is based on a determination of whether the event is chargeable or non-chargeable. Further, the event is allowed if the event is authorized by the event processor.Type: GrantFiled: June 17, 2008Date of Patent: February 19, 2013Assignee: Amdocs Software Systems LimitedInventors: Dalia Zipor, Adi Lachman, Ofer Levi, Ilan Buganim, Felix Margulis
-
Patent number: 8306607Abstract: Characteristics of biological substances, such as cerebral cortex matter, are sensed. According to an example embodiment, the present invention is directed to a negligibly-intrusive, multi-layer integrated circuit arrangement for monitoring activity of an area of a cerebral cortex that would normally be covered by an anatomical layer. The multi-layer integrated circuit arrangement includes an optics layer located outside the cerebral cortex area that includes an emitter and a detector. The optics layer is adapted for implantation in the anatomical layer and for sensing at least one brain-activity parameter. The multi-layered integrated circuit arrangement also includes a data-processing layer that includes a digital-processing circuit that is adapted for assimilating neural data in response to the optics layer sensing at least one brain-activity parameter.Type: GrantFiled: November 1, 2004Date of Patent: November 6, 2012Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Ofer Levi, Evan P. Thrush, James S. Harris, Stepehn J. Smith, Krishna V. Shenoy
-
Publication number: 20120188354Abstract: The present invention uses vertical-cavity surface-emitting lasers (VCSELs) as illumination source for simultaneous imaging of blood flow and tissue oxygenation dynamics in vivo, or a means to monitor neural activity in brain slices ex vivo. The speckle pattern on the brain tissue due to a VCSEL's coherence properties is the main challenge to producing low-noise high-brightness illumination, required for evaluating tissue oxygenation. Moreover, using oxide-confined VCSELs we show a fast switching from a single-mode operation scheme to a special multi-modal, multi-wavelength rapid sweep scheme. The multi-modal, multi-wavelength rapid sweep scheme reduces noise values to within a factor of 40% compared to non-coherent LED illumination, enabling high-brightness VCSELs to act as efficient miniature light sources for various brain imaging modalities and other imaging applications. These VCSELs are promising for long-term portable continuous monitoring of brain dynamics in freely moving animals.Type: ApplicationFiled: January 24, 2012Publication date: July 26, 2012Inventors: Elizabeth Alice Munro, Ofer Levi
-
Patent number: 7604981Abstract: A variety of types of molecules are detected and/or analyzed using an integrated micro-circuit arrangement. According to an example embodiment of the present invention, a micro-circuit arrangement detects excitable target markers in response to an excitation source. The excitation source emits a first electromagnetic radiation to excite one or more target markers into emitting a second electromagnetic radiation. The excitation source and detector combination can be optimized to detect a specific characteristic of a biological specimen. In this manner, an excitation source can be combined with several optical-detectors or detection channels, where each optical-detector is measuring or sensing the same or different characteristic of the biological specimen.Type: GrantFiled: March 7, 2003Date of Patent: October 20, 2009Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: James S. Harris, Jr., Stephen J. Smith, Evan P. Thrush, Ofer Levi